Intrinsic Therapeutics, Inc

Intrinsic Therapeutics, Inc. is a medical device company based in Woburn, Massachusetts, founded in 2000. The company specializes in therapies for treating disc herniations in the spine, particularly for patients undergoing discectomy surgery. Its flagship product, the Barricaid Annular Closure Device, is designed to reconstruct the weakened annulus fibrosus and surrounding tissues, aiming to prevent reherniations after lumbar discectomy procedures. The Barricaid device has shown clinical data indicating an 81% reduction in reherniation-related reoperations for patients with large annular defects. Intrinsic Therapeutics serves spine surgeons and their patients in the United States, focusing on improving patient outcomes and addressing the root causes of recurrent disc herniation and associated low back pain. The company is led by a team of experienced executives dedicated to advancing early spine care.

• Employees86
• Founded2000
• Annual Revenue$12000000
• Total Funding$218568406